SCHEMBL3662307

SCHEMBL3662307

COCN1C(=O)NC(=O)C(c2ccccc2)(c2ccccc2)C1=O.O=C1CC(=O)N(c2ccccc2)C(=O)N1c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
CYP2C19 P33261 2/20 0.34
ALDH1A1 P00352 3/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 2/20 0.33
ELANE P08246 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
RAB9A P51151 1/20 0.32
OPRK1 P41145 1/20 0.32
PDE4D Q08499 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL711198 0.85 LMNA (0.52) LMNACYP2C19ALDH1A1GAAKMT2A
SCHEMBL1861854 0.84 LMNA (0.51) LMNACYP2C19ALDH1A1GAAKMT2A
SCHEMBL3662305 0.80 LMNA (0.48) LMNACYP2C19ALDH1A1CYP2C9MAPT
T-2000 SCHEMBL711204 0.73 LMNA (0.69) LMNACYP2C19ALDH1A1GAAELANE
SCHEMBL5891181 0.72 ALDH1A1 (0.46) LMNACYP2C19ALDH1A1GAAMAPT
SCHEMBL13497193 0.72 LMNA (0.43) LMNACYP2C19CYP1A2MEN1KMT2A
SCHEMBL7599895 0.70 CYP2C19 (0.39) LMNACYP2C19ALDH1A1GAA
SCHEMBL437784 0.69 HPGD (0.59) ALDH1A1GAAHPGDMAPTMEN1
SCHEMBL13002844 0.68 CYP2C19 (0.37) LMNACYP2C19ALDH1A1GAAKMT2A
SCHEMBL14035379 0.66 LMNA (0.63) LMNACYP2C19ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140030322-A1 PHARMACEUTICAL COMPOSITIONS LOCL PHARMA, INC. 2014-01-30 US claimed
US-20120201888-A1 Pharmaceutical Compositions CHARLESTON LABORATORIES, INC. (US) 2012-08-09 US claimed
EP-2240022-A2 PHARMACEUTICAL COMPOSITIONS Charleston Laboratories, Inc. (US) 2010-10-20 EP claimed
WO-2009089494-A2 PHARMACEUTICAL COMPOSITIONS CHARLESTON LABORATORIES, INC. (US) 2009-07-16 WO claimed
US-20090175939-A1 PHARMACEUTICAL COMPOSITIONS CHARLESTON LABORATORIES, INC. (US) 2009-07-09 US claimed
EP-3090743-A1 PHARMACEUTICAL COMPOSITIONS FOR TREATING HEADACHE AND ELIMINATING NAUSEA Charleston Laboratories, Inc. (US) 2016-11-09 EP disclosed